Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 1924

3.
4.

The chemical biology of clinically tolerated NMDA receptor antagonists.

Chen HS, Lipton SA.

J Neurochem. 2006 Jun;97(6):1611-26. Review.

5.
7.

Paradigm shift in neuroprotection by NMDA receptor blockade: memantine and beyond.

Lipton SA.

Nat Rev Drug Discov. 2006 Feb;5(2):160-70. Review.

PMID:
16424917
8.
10.

Possible role for memantine in protecting retinal ganglion cells from glaucomatous damage.

Lipton SA.

Surv Ophthalmol. 2003 Apr;48 Suppl 1:S38-46. Review.

PMID:
12852433
11.

Pharmacotherapeutic approaches to the treatment of Alzheimer's disease.

Standridge JB.

Clin Ther. 2004 May;26(5):615-30. Review.

PMID:
15220008
12.

Open-channel block of N-methyl-D-aspartate (NMDA) responses by memantine: therapeutic advantage against NMDA receptor-mediated neurotoxicity.

Chen HS, Pellegrini JW, Aggarwal SK, Lei SZ, Warach S, Jensen FE, Lipton SA.

J Neurosci. 1992 Nov;12(11):4427-36.

13.

Neuropathologic changes in Alzheimer's disease: potential targets for treatment.

Wenk GL.

J Clin Psychiatry. 2006;67 Suppl 3:3-7; quiz 23. Review.

14.
15.

Neuroprotective properties of memantine in different in vitro and in vivo models of excitotoxicity.

Volbracht C, van Beek J, Zhu C, Blomgren K, Leist M.

Eur J Neurosci. 2006 May;23(10):2611-22.

PMID:
16817864
16.

[Memantine].

Molinuevo JL.

Neurologia. 2003 Jun;18(5):255-61. Review. Spanish.

PMID:
12768511
18.

Efficacy and tolerability of memantine in the treatment of dementia.

Rossom R, Adityanjee, Dysken M.

Am J Geriatr Pharmacother. 2004 Dec;2(4):303-12. Review.

PMID:
15903287
19.

Alzheimer's disease and the glutamate NMDA receptor.

Doraiswamy PM.

Psychopharmacol Bull. 2003 Spring;37(2):41-9. Review.

PMID:
14566213
20.

Evaluation of memantine for the treatment of Alzheimer's disease.

Ferris SH.

Expert Opin Pharmacother. 2003 Dec;4(12):2305-13. Review.

PMID:
14640929

Supplemental Content

Support Center